148 related articles for article (PubMed ID: 34561707)
1. Clinical significance of part-solid lung cancer in the eighth edition TNM staging system.
Okamoto T; Miyawaki M; Toyokawa G; Karashima T; Abe M; Takumi Y; Hashimoto T; Osoegawa A; Tagawa T; Takeuchi H; Shimokawa M; Sugio K
Interact Cardiovasc Thorac Surg; 2022 Jan; 34(2):219-226. PubMed ID: 34561707
[TBL] [Abstract][Full Text] [Related]
2. What is the radiological definition of part-solid tumour in lung cancer?†.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2017 Feb; 51(2):242-247. PubMed ID: 28119328
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm.
Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
Jpn J Clin Oncol; 2020 Oct; 50(11):1306-1312. PubMed ID: 32901276
[TBL] [Abstract][Full Text] [Related]
4. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
[TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer.
Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35293580
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of ground-glass areas within tumours in non-small-cell lung cancer.
Sakurai H; Goto Y; Yoh K; Takamochi K; Shukuya T; Hishida T; Tsuboi M; Yoshida K; Ohde Y; Okumura S; Taguri M; Kunitoh H
Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38598462
[TBL] [Abstract][Full Text] [Related]
7. Comparing Part-Solid and Pure-Solid Tumors in the TNM Classification of Lung Cancer (Eighth Edition).
Yamanashi K; Okumura N; Yamamoto Y; Takahashi A; Nakashima T; Matsuoka T
Thorac Cardiovasc Surg; 2019 Jun; 67(4):306-314. PubMed ID: 29843187
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
[TBL] [Abstract][Full Text] [Related]
9. Prognostic ability of new T1 descriptors in the tumour, node and metastasis classification of surgically treated non-small-cell lung cancer.
Takenaka T; Yamazaki K; Miura N; Takeo S
Interact Cardiovasc Thorac Surg; 2018 Nov; 27(5):714-719. PubMed ID: 29788086
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of solid-part tumour volume doubling time in patients with radiological part-solid or solid lung cancer.
Setojima Y; Shimada Y; Tanaka T; Shigefuku S; Makino Y; Maehara S; Hagiwara M; Masuno R; Yamada T; Kakihana M; Kajiwara N; Ohira T; Ikeda N
Eur J Cardiothorac Surg; 2020 Apr; 57(4):763-770. PubMed ID: 31746987
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer.
Inoue M; Minami M; Sawabata N; Utsumi T; Kadota Y; Shigemura N; Okumura M
Eur J Cardiothorac Surg; 2010 Jun; 37(6):1445-9. PubMed ID: 20137967
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of visceral pleural invasion in pure-solid and part-solid lung cancer patients.
Okada S; Hattori A; Matsunaga T; Takamochi K; Oh S; Inoue M; Suzuki K
Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):303-310. PubMed ID: 32918675
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of solid portions in non-small cell lung cancer-the solid part is not always measurable for clinical T factor.
Fukui M; Takamochi K; Ouchi T; Koike Y; Yaguchi T; Matsunaga T; Hattori A; Suzuki K; Hoshina A; Yamashiro Y; Oh S; Suzuki K
Jpn J Clin Oncol; 2021 Jan; 51(1):114-119. PubMed ID: 33094807
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non-small-cell Lung Cancer.
Chen K; Chen H; Yang F; Sui X; Li X; Wang J
Clin Lung Cancer; 2017 Nov; 18(6):e457-e466. PubMed ID: 28539214
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Pathological Staging Validation in the Eighth Edition of the TNM Classification for Lung Cancer: Correlation between Solid Size on Thin-Section Computed Tomography and Invasive Size in Pathological Findings in the New T Classification.
Aokage K; Miyoshi T; Ishii G; Kusumoto M; Nomura S; Katsumata S; Sekihara K; Hishida T; Tsuboi M
J Thorac Oncol; 2017 Sep; 12(9):1403-1412. PubMed ID: 28627462
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma.
Song SH; Ahn JH; Lee HY; Lee G; Choi JY; Kang J; Kim EY; Han J; Kwon OJ; Lee KS; Kim HK; Choi YS; Kim J; Shim YM
Eur Radiol; 2016 Jun; 26(6):1538-46. PubMed ID: 26455720
[TBL] [Abstract][Full Text] [Related]
17. Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Eur J Cardiothorac Surg; 2017 Mar; 51(3):518-525. PubMed ID: 28082475
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.
Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Aokage K; Saji H; Watanabe SI;
J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1469-1480. PubMed ID: 32451073
[TBL] [Abstract][Full Text] [Related]
19. Significance of preoperative biopsy in radiological solid-dominant clinical stage I non-small-cell lung cancer.
Huang CS; Chien HC; Chen CK; Yeh YC; Hsu PK; Chen HS; Hsieh CC; Hsu HS; Huang BS; Shih CC
Interact Cardiovasc Thorac Surg; 2021 Apr; 32(4):537-545. PubMed ID: 33332546
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of Early-stage Part-solid and Pure-solid Lung Adenocarcinomas.
Kinoshita F; Toyokawa G; Matsubara T; Kozuma Y; Haratake N; Takamori S; Akamine T; Hirai F; Takenaka T; Tagawa T; Maehara Y
Anticancer Res; 2019 May; 39(5):2665-2670. PubMed ID: 31092466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
